Melanie Drolet, Ph.D. - Publications

Affiliations: 
2005 Universite Laval (Canada) 
Area:
Public Health, Industrial Psychology

52/85 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Canfell K, Kim JJ, Brisson M, Keane A, Simms KT, Caruana M, Burger EA, Martin D, Nguyen DTN, Bénard É, Sy S, Regan C, Drolet M, Gingras G, Laprise JF, et al. Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries. Lancet (London, England). PMID 32007142 DOI: 10.1016/S0140-6736(20)30157-4  0.41
2020 Brisson M, Kim JJ, Canfell K, Drolet M, Gingras G, Burger EA, Martin D, Simms KT, Bénard É, Boily MC, Sy S, Regan C, Keane A, Caruana M, Nguyen DTN, et al. Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries. Lancet (London, England). PMID 32007141 DOI: 10.1016/S0140-6736(20)30068-4  0.413
2020 Drolet M, Brisson M. Population-level impact of human papillomavirus vaccination - Authors' reply. Lancet (London, England). PMID 31972129 DOI: 10.1016/S0140-6736(19)33158-7  0.331
2019 Whitworth HS, Gallagher KE, Howard N, Mounier-Jack S, Mbwanji G, Kreimer AR, Basu P, Kelly H, Drolet M, Brisson M, Watson-Jones D. Efficacy and immunogenicity of a single dose of human papillomavirus vaccine compared to no vaccination or standard three and two-dose vaccination regimens: A systematic review of evidence from clinical trials. Vaccine. PMID 31870572 DOI: 10.1016/J.Vaccine.2019.12.017  0.336
2019 Humphries B, Lauzier S, Drolet M, Coyle D, Mâsse B, Provencher L, Robidoux A, Maunsell E. Wage losses among spouses of women with nonmetastatic breast cancer. Cancer. PMID 31821547 DOI: 10.1002/Cncr.32638  0.693
2019 Laprise JF, Chesson HW, Markowitz LE, Drolet M, Martin D, Bénard É, Brisson M. Effectiveness and Cost-Effectiveness of Human Papillomavirus Vaccination Through Age 45 Years in the United States. Annals of Internal Medicine. PMID 31816629 DOI: 10.7326/M19-1182  0.417
2019 Drolet M, Zhou Z, Sauvageau C, DeWals P, Gilca V, Amini R, Bénard É, Brisson M. Effectiveness and cost-effectiveness of vaccination against herpes zoster in Canada: a modelling study. Cmaj : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne. 191: E932-E939. PMID 31451524 DOI: 10.1503/Cmaj.190274  0.343
2019 Drolet M, Bénard É, Pérez N, Brisson M. Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis. Lancet (London, England). PMID 31255301 DOI: 10.1097/Ogx.0000000000000724  0.396
2019 Brisson M, Drolet M. Global elimination of cervical cancer as a public health problem. The Lancet. Oncology. PMID 30795952 DOI: 10.1016/S1470-2045(19)30072-5  0.324
2018 Drolet M, Bénard É, Jit M, Hutubessy R, Brisson M. Model Comparisons of the Effectiveness and Cost-Effectiveness of Vaccination: A Systematic Review of the Literature. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 21: 1250-1258. PMID 30314627 DOI: 10.1016/J.Jval.2018.03.014  0.341
2018 Markowitz LE, Drolet M, Perez N, Jit M, Brisson M. Human papillomavirus vaccine effectiveness by number of doses: Systematic review of data from national immunization programs. Vaccine. PMID 29802000 DOI: 10.1016/J.Vaccine.2018.01.057  0.335
2017 Drolet M, Laprise JF, Brotherton JML, Donovan B, Fairley CK, Ali H, Bénard É, Martin D, Brisson M. The impact of human papillomavirus catch-up vaccination in Australia: Implications for introduction of multiple age cohort vaccination and post-vaccination data interpretation. The Journal of Infectious Diseases. PMID 28968800 DOI: 10.1093/Infdis/Jix476  0.362
2017 Lemieux-Mellouki P, Drolet M, Jit M, Gingras G, Brisson M. Modelling multi-site transmission of the human papillomavirus and its impact on vaccination effectiveness. Epidemics. 21: 80-87. PMID 28916210 DOI: 10.1016/J.Epidem.2017.08.001  0.353
2017 Looker kj, Rönn MM, Brock PM, Brisson M, Drolet M, Mayaud P, Boily M. LB1.2 What is the strength of evidence for hiv and hpv interactions? results from systematic reviews and meta-analyses of longitudinal studies Sexually Transmitted Infections. 93. DOI: 10.1136/Sextrans-2017-053264.103  0.316
2016 Brisson M, Bénard É, Drolet M, Bogaards JA, Baussano I, Vänskä S, Jit M, Boily MC, Smith MA, Berkhof J, Canfell K, Chesson HW, Burger EA, Choi YH, De Blasio BF, et al. Population-level impact, herd immunity, and elimination after human papillomavirus vaccination: a systematic review and meta-analysis of predictions from transmission-dynamic models. The Lancet. Public Health. 1: e8-e17. PMID 29253379 DOI: 10.1016/S2468-2667(16)30001-9  0.388
2016 Brisson M, Drolet M, Bénard É, Kreimer AR. Effect of HPV on cervical cancer screening in Alberta. Cmaj : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne. 188: 1035. PMID 27698024 DOI: 10.1503/Cmaj.1150121  0.378
2016 Mesher D, Soldan K, Lehtinen M, Beddows S, Brisson M, Brotherton JM, Chow EP, Cummings T, Drolet M, Fairley CK, Garland SM, Kahn JA, Kavanagh K, Markowitz L, Pollock KG, et al. Population-Level Effects of Human Papillomavirus Vaccination Programs on Infections with Nonvaccine Genotypes. Emerging Infectious Diseases. 22: 1732-1740. PMID 27648688 DOI: 10.3201/Eid2210.160675  0.363
2016 Laprise JF, Markowitz LE, Chesson HW, Drolet M, Brisson M. COMPARING 2- AND 3-DOSE 9-VALENT HPV VACCINE SCHEDULES IN THE U.S.: A COST-EFFECTIVENESS ANALYSIS. The Journal of Infectious Diseases. PMID 27234416 DOI: 10.1093/Infdis/Jiw227  0.344
2016 Drolet M, Deeks SL, Kliewer E, Musto G, Lambert P, Brisson M. Can high overall human papillomavirus vaccination coverage hide sociodemographic inequalities? An ecological analysis in Canada. Vaccine. 34: 1874-80. PMID 26954465 DOI: 10.1016/J.Vaccine.2016.02.069  0.359
2016 Brisson M, Laprise JF, Chesson HW, Drolet M, Malagón T, Boily MC, Markowitz LE. Health and Economic Impact of Switching from a 4-Valent to a 9-Valent HPV Vaccination Program in the United States. Journal of the National Cancer Institute. 108. PMID 26438574 DOI: 10.1093/Jnci/Djv282  0.379
2015 Drolet M, Bénard É, Boily MC, Ali H, Baandrup L, Bauer H, Beddows S, Brisson J, Brotherton JM, Cummings T, Donovan B, Fairley CK, Flagg EW, Johnson AM, Kahn JA, et al. Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis. The Lancet. Infectious Diseases. 15: 565-80. PMID 25744474 DOI: 10.1016/S1473-3099(14)71073-4  0.368
2015 Malagón T, Drolet M, Boily MC, Laprise JF, Brisson M. Changing inequalities in cervical cancer: modeling the impact of vaccine uptake, vaccine herd effects, and cervical cancer screening in the post-vaccination era. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 24: 276-85. PMID 25380735 DOI: 10.1158/1055-9965.Epi-14-1052  0.415
2014 Laprise JF, Drolet M, Boily MC, Jit M, Sauvageau C, Franco EL, Lemieux-Mellouki P, Malagón T, Brisson M. Comparing the cost-effectiveness of two- and three-dose schedules of human papillomavirus vaccination: a transmission-dynamic modelling study. Vaccine. 32: 5845-53. PMID 25131743 DOI: 10.1016/J.Vaccine.2014.07.099  0.37
2014 Jit M, Choi YH, Laprise JF, Boily MC, Drolet M, Brisson M. Two-dose strategies for human papillomavirus vaccination: how well do they need to protect? Vaccine. 32: 3237-42. PMID 24726246 DOI: 10.1016/J.Vaccine.2014.03.098  0.342
2014 Drolet M, Laprise JF, Boily MC, Franco EL, Brisson M. Potential cost-effectiveness of the nonavalent human papillomavirus (HPV) vaccine. International Journal of Cancer. Journal International Du Cancer. 134: 2264-8. PMID 24174175 DOI: 10.1002/Ijc.28541  0.4
2013 Drolet M, Boily MC, Van de Velde N, Franco EL, Brisson M. Vaccinating Girls and Boys with Different Human Papillomavirus Vaccines: Can It Optimise Population-Level Effectiveness? Plos One. 8: e67072. PMID 23840589 DOI: 10.1371/Journal.Pone.0067072  0.362
2013 Brisson M, Laprise JF, Drolet M, Van de Velde N, Franco EL, Kliewer EV, Ogilvie G, Deeks SL, Boily MC. Comparative cost-effectiveness of the quadrivalent and bivalent human papillomavirus vaccines: a transmission-dynamic modeling study. Vaccine. 31: 3863-71. PMID 23830974 DOI: 10.1016/J.Vaccine.2013.06.064  0.385
2013 Drolet M, Boily MC, Greenaway C, Deeks SL, Blanchette C, Laprise JF, Brisson M. Sociodemographic inequalities in sexual activity and cervical cancer screening: implications for the success of human papillomavirus vaccination. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 22: 641-52. PMID 23549400 DOI: 10.1158/1055-9965.Epi-12-1173  0.393
2013 Malagón T, Joumier V, Boily MC, Van de Velde N, Drolet M, Brisson M. The impact of differential uptake of HPV vaccine by sexual risks on health inequalities: a model-based analysis. Vaccine. 31: 1740-7. PMID 23384753 DOI: 10.1016/J.Vaccine.2013.01.026  0.356
2013 Lauzier S, Levesque P, Mondor M, Drolet M, Coyle D, Brisson J, Masse B, Provencher L, Robidoux A, Maunsell E. Out-of-pocket costs in the year after early breast cancer among canadian women and spouses Journal of the National Cancer Institute. 105: 280-292. PMID 23349250 DOI: 10.1093/Jnci/Djs512  0.69
2013 Drolet M, Oxman MN, Levin MJ, Schmader KE, Johnson RW, Patrick D, Mansi JA, Brisson M. Vaccination against herpes zoster in developed countries: state of the evidence. Human Vaccines & Immunotherapeutics. 9: 1177-84. PMID 23324598 DOI: 10.4161/Hv.23491  0.345
2013 Brisson M, Drolet M, Malagón T. Inequalities in human papillomavirus (HPV)-associated cancers: Implications for the success of HPV vaccination Journal of the National Cancer Institute. 105: 158-161. PMID 23297040 DOI: 10.1093/Jnci/Djs638  0.377
2013 Owen BN, Brock PM, Baggaley RF, Butler AR, Pickles M, Brisson M, Drolet M, Boily M. P3.003 Heterosexual Anal Intercourse Among Youth: A Systematic Review and Metaanalysis Sexually Transmitted Infections. 89: A148.3-A148. DOI: 10.1136/Sextrans-2013-051184.0463  0.301
2013 Owen BN, Brock PM, Shubber Z, Baggaley RF, Butler AR, Pickles M, Brisson M, Drolet M, Boily M. 31. Lifetime prevalence of anal intercourse among sexually active female youth and young female sex workers: a comparative systematic review and meta-analysis Sexual Health. 10: 585. DOI: 10.1071/Shv10N6Ab31  0.305
2012 Van de Velde N, Boily MC, Drolet M, Franco EL, Mayrand MH, Kliewer EV, Coutlée F, Laprise JF, Malagón T, Brisson M. Population-level impact of the bivalent, quadrivalent, and nonavalent human papillomavirus vaccines: a model-based analysis. Journal of the National Cancer Institute. 104: 1712-23. PMID 23104323 DOI: 10.1093/Jnci/Djs395  0.366
2012 Malagón T, Drolet M, Boily MC, Franco EL, Jit M, Brisson J, Brisson M. Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis. The Lancet. Infectious Diseases. 12: 781-9. PMID 22920953 DOI: 10.1016/S1473-3099(12)70187-1  0.358
2012 Drolet M, Levin MJ, Schmader KE, Johnson R, Oxman MN, Patrick D, Fournier SO, Mansi JA, Brisson M. Employment related productivity loss associated with herpes zoster and postherpetic neuralgia: a 6-month prospective study. Vaccine. 30: 2047-50. PMID 22285632 DOI: 10.1016/J.Vaccine.2012.01.045  0.323
2012 Drolet M, Brisson M, Maunsell E, Franco EL, Coutlée F, Ferenczy A, Fisher W, Mansi JA. The psychosocial impact of an abnormal cervical smear result. Psycho-Oncology. 21: 1071-81. PMID 21695747 DOI: 10.1002/Pon.2003  0.62
2011 Drolet M, Brisson M, Maunsell E, Franco EL, Coutlée F, Ferenczy A, Ratnam S, Fisher W, Mansi JA. The impact of anogenital warts on health-related quality of life: a 6-month prospective study. Sexually Transmitted Diseases. 38: 949-56. PMID 21934571 DOI: 10.1097/Olq.0B013E3182215512  0.626
2011 Lauzier S, Levesque P, Drolet M, Coyle D, Brisson J, Mâsse B, Robidoux A, Robert J, Maunsell E. Out-of-pocket costs for accessing adjuvant radiotherapy among Canadian women with breast cancer Journal of Clinical Oncology. 29: 4007-4013. PMID 21931023 DOI: 10.1200/Jco.2011.35.1007  0.687
2011 Brisson M, van de Velde N, Franco EL, Drolet M, Boily MC. Incremental impact of adding boys to current human papillomavirus vaccination programs: role of herd immunity. The Journal of Infectious Diseases. 204: 372-6. PMID 21742835 DOI: 10.1093/Infdis/Jir285  0.366
2010 Drolet M, Brisson M, Schmader KE, Levin MJ, Johnson R, Oxman MN, Patrick D, Blanchette C, Mansi JA. The impact of herpes zoster and postherpetic neuralgia on health-related quality of life: a prospective study. Cmaj : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne. 182: 1731-6. PMID 20921251 DOI: 10.1503/Cmaj.091711  0.318
2010 Lauzier S, Maunsell E, Drolet M, Coyle D, Hébert-Croteau N. Validity of information obtained from a method for estimating cancer costs from the perspective of patients and caregivers Quality of Life Research. 19: 177-189. PMID 20094806 DOI: 10.1007/S11136-009-9575-Y  0.646
2008 Lauzier S, Maunsell E, Drolet M, Coyle D, Hébert-Croteau N, Brisson J, Mâsse B, Abdous B, Robidoux A, Robert J. Wage losses in the year after breast cancer: Extent and determinants among Canadian women Journal of the National Cancer Institute. 100: 321-332. PMID 18314472 DOI: 10.1093/Jnci/Djn028  0.7
2007 Lauzier S, Maunsell E, Drolet M, Hébert-Croteau N, Brisson J, Coyle D, Masse B, Abdous B, Robidoux A, Robert J. Financial burden from wage losses after early breast cancer: Extent and determinants among Canadian women Journal of Clinical Oncology. 25: 9000-9000. DOI: 10.1200/Jco.2007.25.18_Suppl.9000  0.704
2006 Dorval M, Drolet M, Leblanc M, Maunsell E, Dugas MJ, Simard J. Using the impact of event scale to evaluate distress in the context of genetic testing for breast cancer susceptibility Psychological Reports. 98: 873-881. PMID 16933689 DOI: 10.2466/Pr0.98.3.873-881  0.641
2005 Drolet M, Maunsell E, Brisson J, Brisson C, Mâsse B, Deschênes L. Not working 3 years after breast cancer: Predictors in a population-based study Journal of Clinical Oncology. 23: 8305-8312. PMID 16219927 DOI: 10.1200/Jco.2005.09.500  0.699
2005 Drolet M, Maunsell E, Mondor M, Brisson C, Brisson J, Mâsse B, Deschênes L. Work absence after breast cancer diagnosis: A population-based study Cmaj. 173: 765-769. PMID 16186583 DOI: 10.1503/Cmaj.050178  0.705
2005 Maunsell E, Drolet M, Ouhoummane N, Robert J. Breast cancer survivors accurately reported key treatment and prognostic characteristics Journal of Clinical Epidemiology. 58: 364-369. PMID 15862722 DOI: 10.1016/J.Jclinepi.2004.09.005  0.66
2005 Lauzier S, Maunsell E, De Koninck M, Drolet M, Hébert-Croteau N, Robert J. Conceptualization and sources of costs from breast cancer: Findings from patient and caregiver focus groups Psycho-Oncology. 14: 351-360. PMID 15386763 DOI: 10.1002/Pon.851  0.688
2004 Maunsell E, Drolet M, Brisson J, Brisson C, Mâsse B, Deschênes L. Work situation after breast cancer: Results from a population-based study Journal of the National Cancer Institute. 96: 1813-1822. PMID 15601637 DOI: 10.1093/Jnci/Djh335  0.705
2002 Maunsell E, Drolet M, Brisson J, Robert J, Deschênes L. Dietary change after breast cancer: Extent, predictors, and relation with psychological distress Journal of Clinical Oncology. 20: 1017-1025. PMID 11844825 DOI: 10.1200/Jco.20.4.1017  0.674
Low-probability matches (unlikely to be authored by this person)
2010 Brisson M, Melkonyan G, Drolet M, De Serres G, Thibeault R, De Wals P. Modeling the impact of one- and two-dose varicella vaccination on the epidemiology of varicella and zoster Vaccine. 28: 3385-3397. PMID 20199763 DOI: 10.1016/J.Vaccine.2010.02.079  0.296
2018 Looker KJ, Rönn MM, Brock PM, Brisson M, Drolet M, Mayaud P, Boily MC. Evidence of synergistic relationships between HIV and Human Papillomavirus (HPV): systematic reviews and meta-analyses of longitudinal studies of HPV acquisition and clearance by HIV status, and of HIV acquisition by HPV status. Journal of the International Aids Society. 21: e25110. PMID 29873885 DOI: 10.1002/Jia2.25110  0.285
2021 Drolet M, Laprise JF, Martin D, Jit M, Bénard É, Gingras G, Boily MC, Alary M, Baussano I, Hutubessy R, Brisson M. Optimal human papillomavirus vaccination strategies to prevent cervical cancer in low-income and middle-income countries in the context of limited resources: a mathematical modelling analysis. The Lancet. Infectious Diseases. PMID 34245682 DOI: 10.1016/S1473-3099(20)30860-4  0.285
2010 Brisson M, Sénécal M, Drolet M, Mansi JA. Health-related quality of life lost to rotavirus-associated gastroenteritis in children and their parents: a Canadian prospective study. The Pediatric Infectious Disease Journal. 29: 73-5. PMID 19907361 DOI: 10.1097/Inf.0B013E3181B41506  0.283
2015 Lemieux-Mellouki P, Drolet M, Brisson J, Franco EL, Boily MC, Baussano I, Brisson M. Assortative mixing as a source of bias in epidemiological studies of sexually transmitted infections: the case of smoking and human papillomavirus. Epidemiology and Infection. 1-10. PMID 26584685 DOI: 10.1017/S0950268815002915  0.28
2010 Drolet M, Brisson M, Schmader K, Levin M, Johnson R, Oxman M, Patrick D, Camden S, Mansi JA. Predictors of postherpetic neuralgia among patients with herpes zoster: a prospective study. The Journal of Pain : Official Journal of the American Pain Society. 11: 1211-21. PMID 20434957 DOI: 10.1016/J.Jpain.2010.02.020  0.275
2023 Prem K, Choi YH, Bénard É, Burger EA, Hadley L, Laprise JF, Regan MC, Drolet M, Sy S, Abbas K, Portnoy A, Kim JJ, Brisson M, Jit M. Global impact and cost-effectiveness of one-dose versus two-dose human papillomavirus vaccination schedules: a comparative modelling analysis. Bmc Medicine. 21: 313. PMID 37635227 DOI: 10.1186/s12916-023-02988-3  0.27
2016 Drolet M, Deeks SL, Kliewer E, Musto G, Lambert P, Brisson M. Can high overall human papillomavirus vaccination coverage hide sociodemographic inequalities? An ecological analysis in Canada Vaccine. 34: 1874-1880. DOI: 10.1016/j.vaccine.2016.02.069  0.249
2022 Staadegaard L, Rönn MM, Soni N, Bellerose ME, Bloem P, Brisson M, Maheu-Giroux M, Barnabas RV, Drolet M, Mayaud P, Dalal S, Boily MC. Immunogenicity, safety, and efficacy of the HPV vaccines among people living with HIV: A systematic review and meta-analysis. Eclinicalmedicine. 52: 101585. PMID 35936024 DOI: 10.1016/j.eclinm.2022.101585  0.244
2023 Bénard É, Drolet M, Laprise JF, Gingras G, Jit M, Boily MC, Bloem P, Brisson M. Potential population-level effectiveness of one-dose HPV vaccination in low-income and middle-income countries: a mathematical modelling analysis. The Lancet. Public Health. 8: e788-e799. PMID 37777288 DOI: 10.1016/S2468-2667(23)00180-9  0.24
2022 Bénard É, Drolet M, Laprise JF, Jit M, Prem K, Boily MC, Brisson M. Potential benefit of extended dose schedules of human papillomavirus vaccination in the context of scarce resources and COVID-19 disruptions in low-income and middle-income countries: a mathematical modelling analysis. The Lancet. Global Health. 11: e48-e58. PMID 36521952 DOI: 10.1016/S2214-109X(22)00475-2  0.238
2010 Drolet M, Brisson M, Levin MJ, Schmader KE, Oxman MN, Johnson RW, Camden S, Mansi JA. A prospective study of the herpes zoster severity of illness. The Clinical Journal of Pain. 26: 656-66. PMID 20842005 DOI: 10.1097/Ajp.0B013E3181Eef686  0.23
1997 Noreau L, Moffet H, Drolet M, Parent E. Dance-based exercise program in rheumatoid arthritis: Feasibility in individuals with American College of Rheumatology Functional Class III disease American Journal of Physical Medicine and Rehabilitation. 76: 109-113. PMID 9129516 DOI: 10.1097/00002060-199703000-00005  0.229
2000 Noreau L, Proulx P, Gagnon L, Drolet M, Laramée MT. Secondary impairments after spinal cord injury: A population-based study American Journal of Physical Medicine and Rehabilitation. 79: 526-535. PMID 11083303 DOI: 10.1097/00002060-200011000-00009  0.227
2000 Moffet H, Noreau L, Parent E, Drolet M. Feasibility of an eight-week dance-based exercise program and its effects on locomotor ability of persons with functional class III rheumatoid arthritis Arthritis Care and Research. 13: 100-111. PMID 14635283 DOI: 10.1002/1529-0131(200004)13:2<100::Aid-Anr4>3.0.Co;2-V  0.223
1999 Drolet M, Noreau L, Vachon J, Moffet H. Muscle strength changes as measured by dynamometry following functional rehabilitation in individuals with spinal cord injury Archives of Physical Medicine and Rehabilitation. 80: 791-800. PMID 10414764 DOI: 10.1016/S0003-9993(99)90229-0  0.219
2022 Markowitz LE, Drolet M, Lewis RM, Lemieux-Mellouki P, Pérez N, Jit M, Brotherton JM, Ogilvie G, Kreimer AR, Brisson M. Human papillomavirus vaccine effectiveness by number of doses: Updated systematic review of data from national immunization programs. Vaccine. PMID 35965239 DOI: 10.1016/j.vaccine.2022.06.065  0.217
2016 Gingras G, Guertin MH, Laprise JF, Drolet M, Brisson M. Mathematical Modeling of the Transmission Dynamics of Clostridium difficile Infection and Colonization in Healthcare Settings: A Systematic Review. Plos One. 11: e0163880. PMID 27690247 DOI: 10.1371/Journal.Pone.0163880  0.203
2011 Benbernou A, Drolet M, Levin MJ, Schmader KE, Oxman MN, Johnson R, Patrick D, Camden S, Mansi JA, Brisson M. Association between prodromal pain and the severity of acute herpes zoster and utilization of health care resources. European Journal of Pain (London, England). 15: 1100-6. PMID 21600819 DOI: 10.1016/J.Ejpain.2011.04.014  0.202
2021 Carazo S, Talbot D, Boulianne N, Brisson M, Gilca R, Deceuninck G, Brousseau N, Drolet M, Ouakki M, Sauvageau C, Barkati S, Fortin É, Carignan A, De Wals P, Skowronski DM, et al. Single-dose mRNA vaccine effectiveness against SARS-CoV-2 in healthcare workers extending 16 weeks post-vaccination: a test-negative design from Quebec, Canada. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 34460902 DOI: 10.1093/cid/ciab739  0.177
2006 Couture D, Perron R, Lalonde L, Curpen B, Warren Burhenne L, Lacaille Bélanger P, Drolet M, Gagné P, Blais G, Garceau J, Bassett L, Tabar L. 2210 Le cancer du sein, une approche multidisciplinaire (sixieme edition-2006) Journal De Radiologie. 87: 1161. DOI: 10.1016/S0221-0363(06)86532-7  0.177
2023 Yokoji K, Giguère K, Malagón T, Rönn MM, Mayaud P, Kelly H, Delany-Moretlwe S, Drolet M, Brisson M, Boily MC, Maheu-Giroux M. Association of naturally acquired type-specific HPV antibodies and subsequent HPV re-detection: systematic review and meta-analysis. Infectious Agents and Cancer. 18: 70. PMID 37941016 DOI: 10.1186/s13027-023-00546-3  0.174
2004 Couture D, Perron R, Lalonde L, Curpen B, Warren Burhenne L, Dufresne M, Bélanger-Lacaille P, Drolet M, Garceau J, Tabar L, Bassett L. S10 Le cancer du sein, approche multidisciplinaire Journal De Radiologie. 85: 1570. DOI: 10.1016/S0221-0363(04)77909-3  0.174
2022 Godbout A, Drolet M, Mondor M, Simard M, Sauvageau C, De Serres G, Brisson M. Time trends in social contacts of individuals according to comorbidity and vaccination status, before and during the COVID-19 pandemic. Bmc Medicine. 20: 199. PMID 35606803 DOI: 10.1186/s12916-022-02398-x  0.156
2022 Skowronski DM, Febriani Y, Ouakki M, Setayeshgar S, El Adam S, Zou M, Talbot D, Prystajecky N, Tyson JR, Gilca R, Brousseau N, Deceuninck G, Galanis E, Fjell CD, Sbihi H, ... ... Drolet M, et al. Two-dose SARS-CoV-2 vaccine effectiveness with mixed schedules and extended dosing intervals: test-negative design studies from British Columbia and Quebec, Canada. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 35438175 DOI: 10.1093/cid/ciac290  0.146
1997 Halpern MT, Brown RE, Drolet M, Sorensen SV, Mandell LA. Decision analysis modelling of costs and outcomes following cefepime monotherapy in Canada. The Canadian Journal of Infectious Diseases = Journal Canadien Des Maladies Infectieuses. 8: 19-27. PMID 22514473 DOI: 10.1155/1997/106462  0.118
2016 Marotta P, Bailey R, Elkashab M, Farley J, Feinman SV, Peltekian K, Poliquin M, Witt-Sullivan H, Rampakakis E, Drolet M, Cooper C. Real-world effectiveness of peginterferon α-2b plus ribavirin in a Canadian cohort of treatment-naïve chronic hepatitis C patients with genotypes 2 or 3: results of the PoWer and RediPEN studies. European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology. PMID 26851949 DOI: 10.1007/s10096-016-2576-1  0.06
2020 Godin A, Xia Y, Buckeridge DL, Mishra S, Douwes-Schultz D, Shen Y, Lavigne M, Drolet M, Schmidt AM, Brisson M, Maheu-Giroux M. The role of case importation in explaining differences in early SARS-CoV-2 transmission dynamics in Canada - a mathematical modeling study of surveillance data. International Journal of Infectious Diseases : Ijid : Official Publication of the International Society For Infectious Diseases. PMID 33115683 DOI: 10.1016/j.ijid.2020.10.046  0.058
2009 Ekoe J, Iliopoulos I, Drolet M, Nasseri N. Insight into people living with type 2 diabetes: a global survey of patients and physicians Canadian Journal of Diabetes. 33: 265. DOI: 10.1016/S1499-2671(09)33207-4  0.057
2022 Drolet M, Godbout A, Mondor M, Béraud G, Drolet-Roy L, Lemieux-Mellouki P, Bureau A, Demers É, Boily MC, Sauvageau C, De Serres G, Hens N, Beutels P, Dervaux B, Brisson M. Time trends in social contacts before and during the COVID-19 pandemic: the CONNECT study. Bmc Public Health. 22: 1032. PMID 35606703 DOI: 10.1186/s12889-022-13402-7  0.053
2018 Feld J, Conway B, Bruneau J, Cooper C, Cox J, Deshaies L, Fraser C, Macphail G, Powis J, Steingart C, Stewart K, Thomas R, Webster D, Drolet M, Mcgovern M, et al. A27 CHARACTERIZATION OF HCV INFECTED PWID IN THE SETTING OF CLINICAL CARE IN CANADA (CAPICA): FINAL RESULTS Journal of the Canadian Association of Gastroenterology. 1: 49-50. DOI: 10.1093/jcag/gwy008.028  0.026
2013 Boily MC, Brisson M, Drolet M, Malagón T. Response. Journal of the National Cancer Institute. 105: 750-1. PMID 23814885 DOI: 10.1093/jnci/djt084  0.01
2013 Brisson M, Drolet M, Boily MC, Malagón T, Franco EL, Laprise J, Van de Velde N, Mayrand MH, Kliewer EV, Coutlée F. Response. Journal of the National Cancer Institute. 105: 664-5. PMID 23767055 DOI: 10.1093/jnci/djt056  0.01
Hide low-probability matches.